ES2034887B1 - PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA. - Google Patents

PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA.

Info

Publication number
ES2034887B1
ES2034887B1 ES9101709A ES9101709A ES2034887B1 ES 2034887 B1 ES2034887 B1 ES 2034887B1 ES 9101709 A ES9101709 A ES 9101709A ES 9101709 A ES9101709 A ES 9101709A ES 2034887 B1 ES2034887 B1 ES 2034887B1
Authority
ES
Spain
Prior art keywords
procedure
extracts
sabal serrulata
sabal
serrulata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9101709A
Other languages
Spanish (es)
Other versions
ES2034887A1 (en
Inventor
Argengol Antonio Manes
Carulla Francisco Mane
Aguirre Jaime Xiol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euromed SA
Original Assignee
Euromed SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euromed SA filed Critical Euromed SA
Priority to ES9101709A priority Critical patent/ES2034887B1/en
Publication of ES2034887A1 publication Critical patent/ES2034887A1/en
Application granted granted Critical
Publication of ES2034887B1 publication Critical patent/ES2034887B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LOS EXTRACTOS LIPIDICOS DE SABAL SERRULATA SE EMPLEAN EN EL TRATAMIENTO DE LAS AFECCIONES PROSTATICAS. LOS PROCEDIMIENTOS DE OBTENCION DE DICHO TIPO DE EXTRACTOS CONOCIDOS HASTA LA FECHA ADOLECEN DE PROBLEMAS DERIVADOS DEL EMPLEO DE DISOLVENTES PELIGROSOS, DESDE EL PUNTO DE VISTA INDUSTRIAL, Y/O TOXICOS. EL PROCEDIMIENTO DE LA PRESENTE INVENCION, QUE RESUELVE DICHOS PROBLEMAS, CONSISTE EN LA EXTRACCION DE LOS FRUTOS MOLIDOS DEL SABAL SERRULATA CON ETANOL DEL 96% EN VOLUMEN Y SE CARACTERIZA PORQUE DICHA ETAPA EXTRACTIVA ESTA PRECEDIDA O SUCEDIDA POR UNA ELIMINACION DE LOS COMPONENTES HIDROFILICOS MEDIANTE EL EMPLEO DE AGUA O MEZCLAS HIDROALCOHOLICAS. EN SU ETAPA FINAL, SE ELIMINA EL ETANOL A PRESION REDUCIDA Y SE PROCEDE A LA DECOLORACION DEL EXTRACTO POR METODOS CONVENCIONALES.LIPIDIC EXTRACTS FROM SABAL SERRULATA ARE USED IN THE TREATMENT OF PROSTATIC CONDITIONS. THE PROCEDURES FOR OBTAINING SUCH TYPE OF EXTRACTS KNOWN TO DATE ADOLVE PROBLEMS DERIVED FROM THE USE OF DANGEROUS SOLVENTS, FROM THE POINT OF INDUSTRIAL, AND / OR TOXIC VIEWS. THE PROCEDURE OF THE PRESENT INVENTION, WHICH SOLVES SUCH PROBLEMS, CONSISTS IN THE EXTRACTION OF THE GROUND FRUITS OF THE SABAL SERRULATA WITH ETHANOL OF 96% IN VOLUME AND IS CHARACTERIZED BECAUSE SUCH EXTRACTIVE STAGE IS PREVIOUS OR SUBSTITUTED BY AN ELIMINES COMPONENT USE OF WATER OR HYDROALCOHOLIC MIXTURES. IN ITS FINAL STAGE, REDUCED PRESSURE ETHANOL IS ELIMINATED AND THE EXTRACT IS COLORED BY CONVENTIONAL METHODS.

ES9101709A 1991-07-11 1991-07-11 PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA. Expired - Fee Related ES2034887B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9101709A ES2034887B1 (en) 1991-07-11 1991-07-11 PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9101709A ES2034887B1 (en) 1991-07-11 1991-07-11 PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA.

Publications (2)

Publication Number Publication Date
ES2034887A1 ES2034887A1 (en) 1993-04-01
ES2034887B1 true ES2034887B1 (en) 1994-02-16

Family

ID=8273082

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9101709A Expired - Fee Related ES2034887B1 (en) 1991-07-11 1991-07-11 PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA.

Country Status (1)

Country Link
ES (1) ES2034887B1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096983B1 (en) * 1970-07-23 1974-05-24 Investigations Scient Pharmace
FR2480754A1 (en) * 1980-04-21 1981-10-23 Fabre Sa Pierre Odourless extract of sabal serrulatum - prepd. under non:oxidising conditions, for treatment of prostate disorders and seborrhoea
EP0068055B1 (en) * 1981-06-26 1986-04-02 P.F. Industrie Process for obtaining a stable, deodorized antiprostatic extract from sabal serrulatum
FR2556968B1 (en) * 1983-12-22 1988-09-16 Pf Medicament TOPICAL DERMATOLOGICAL COMPOSITION FOR THE TREATMENT OF ACNE, BASED ON A LIPID FRACTION EXTRACTED FROM SERENOA REPENS FRUITS
JPS60215608A (en) * 1984-04-11 1985-10-29 Shiseido Co Ltd Hair tonic preparation
IT1188633B (en) * 1986-03-27 1988-01-20 Lampugnani Farmaceutici Spa Two=stage extn. of palm fruits with different solvents
IT1190129B (en) * 1986-06-17 1988-02-10 Indena Spa OILAGINOUS FRUITS EXTRACTION PROCEDURE
IT1203934B (en) * 1987-04-17 1989-02-23 Consiglio Nazionale Ricerche PHARMACEUTICAL COMPOSITIONS CONTAINING HIGHER ALCOHOLS FOR THE TREATMENT OF PROSTATE DISEASES
FR2643375B1 (en) * 1989-02-20 1991-06-07 Fabre Pierre Cosmetique PROCESS FOR THE PREPARATION OF ODORLESS SERENOA REPENS EXTRACT

Also Published As

Publication number Publication date
ES2034887A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
Sharifi-Rad et al. In vitro and in vivo assessment of free radical scavenging and antioxidant activities of Veronica persica Poir
Mohandas et al. Antioxidant activities of terpenoids from Thuidium tamariscellum (C. Muell.) Bosch. and Sande-Lac. a Moss
AU4902299A (en) Composition containing pyrrolizidine-alkaloid-free petasites
ES2104121T3 (en) VARIANT OF A PROTEASE INHIBITOR, OF THE KUNITZ TYPE, OF HUMAN ORIGIN.
ES2060197T3 (en) COMPOSITION BASED ON HYDRATED LIPIDIC LAMP PHASES OR LIPOSOMES CONTAINING AT LEAST ONE LABDANE DERIVATIVE, OR A PLANT EXTRACT CONTAINING IT; COSMETIC OR PHARMACEUTICAL COMPOSITION, PARTICULARLY DERMATOLOGICAL THAT INCORPORATES IT.
ES2078048T3 (en) GRAPHIC DESIGN SYSTEM.
Ansari et al. A brief review on phytochemical and pharmacological profile of Carissa spinarum L
AR002909A1 (en) FUNGICIDE COMPOSITION AND PROCEDURE TO FIGHT PHYTOPATHOGEN FUNGI.
DK0464298T3 (en) Echinacea extracts, processes for their preparation and formulations containing them
ES2034887B1 (en) PROCEDURE FOR OBTAINING ESSENTIALLY LIPIDIC EXTRACTS FROM SABAL SERRULATA.
ES2137918T3 (en) MUTANTS OF ANTITROMBINE III HUMAN.
ES2081783T3 (en) MAPPIA FOETIDA ALKALOIDS, THEIR USE AND THE FORMULATIONS CONTAINING THEM.
ES2034888B1 (en) PROCEDURE FOR OBTAINING THE TOTAL ACID FRACTION OF THE LIPID EXTRACTS OF THE FRUITS OF THE SABAL SERRULATA.
DK438779A (en) BITTER MEDIA
ES2159357T3 (en) TERPENOID DERIVATIVES (SARCODICTINES) USEFUL AS ANTITUMOR AGENTS.
DK0633887T3 (en) Antiviral Calanolid Compounds, Preparations and Uses thereof
Ansori Alpinia galanga or lengkuas (Zingiberaceae): A possible treatment for COVID-19
JPS6419014A (en) Skin-beautifying cosmetic
ES2094914T3 (en) ANTINEOPLASTIC CHEMOTHERAPY OF PLANT ORIGIN, WITH HIGH SELECTIVITY AND VERY REDUCED TOXICITY, AND PROCEDURE FOR ITS PREPARATION.
Al-kubaisy et al. Changes in the Oxidative Stress Biomarkers in Rat Liver Tissue Exposed to Cadmium and Protect with Hibiscus sabdariffa L.(Rossle) Flower Extract
DE3373099D1 (en) Extract of plants of the family of hypoxidaceae for treatment of cancer
Gupta Review on heena plant (Lawsonia inermis) and its applications
Ogunlana et al. Assessment of the scavenging activity of crude methanolic stem bark extract of Newbouldia laevis on selected free radicals
El-Kady The Religious Concept of the Dual Character of the Turtle in Graeco-roman Egypt
Chaudhary et al. A review on pharmacological activities of Turmeric

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19981106

GC2A Exploitation certificate registered application with search report

Effective date: 20030110

FD2A Announcement of lapse in spain

Effective date: 20110822